OPTIMUM GOLF TECHNOLOGIES LIMITED
Company number 07471211 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Optimum Golf Technologies Limited
1. Financial Health Score: A (Excellent)
The company exhibits a picture of strong, sustained vitality. Its financial vital signs—liquidity, profitability, and solvency—are all remarkably healthy, and it is growing at a robust pace without taking on excessive risk. There are no signs of distress.
2. Key Vital Signs
| Vital Sign | Current Reading (2025) | Trend | Interpretation |
|---|---|---|---|
| Net Assets (Shareholders’ Funds) | £3,370,634 | ↑ ↑ 52% YoY | A strong, rapidly growing equity base. The company is building substantial internal reserves. |
| Working Capital (Net Current Assets) | £4,538,515 | ↑ 47% YoY | Excellent short-term financial health. The company has more than enough current assets to cover its immediate debts. |
| Current Ratio | 2.52 | → Stable | A classic sign of a healthy “buffer.” The company can easily meet short-term obligations. |
| Quick Ratio (Acid Test) | 1.54 | → Stable | Even without selling stock, the company can cover all current liabilities—a very strong liquidity position. |
| Cash & Equivalents | £1,479,153 | ↑ 6.5% YoY | A healthy cash reserve, providing a cushion for unexpected needs or investment opportunities. |
| Debt-to-Equity (Total Liabilities / Equity) | 1.31 | ↑ Slightly | Moderate leverage. The company uses debt to finance growth but remains well within a safe range. |
| Retained Earnings Growth | £1,149,164 profit retained | ↑ Strong | Clear evidence of consistent profitability. The business is generating real value for shareholders. |
3. Diagnosis
Overall Condition: Excellent – “Peak Fitness”
The company’s financial body is in top shape. It has a strong heart (ample working capital), healthy lungs (plenty of cash), and is continuously building muscle (growing net assets and retained earnings). The rapid expansion in both stock and debtors suggests a surge in sales – a positive “symptom” of growth rather than distress. The balance sheet is well-structured, with liabilities well-covered by assets and cash flow.
Minor observation (not a symptom of illness): The significant increase in trade debtors (£1.17M) and inventory (£1.20M) in 2025 warrants ongoing monitoring. If not managed carefully, rapid growth can strain the cash conversion cycle. However, the company’s strong cash position and working capital provide more than adequate protection.
4. Recommendations
To maintain this excellent health and prepare for future growth, consider the following prescriptions:
- Manage the Growth Spurt: Keep a close eye on debtor days (how quickly customers pay) and inventory turnover. Consider tightening credit terms or using early-payment discounts to avoid any future cash drag.
- Deploy the Cash Cushion: With £1.48M in the bank and no immediate liquidity needs, explore opportunities to invest surplus cash in income-generating assets—such as expanding the product range, acquiring complementary technology, or building a stronger online platform.
- Review Financing Structure: The moderate level of debt is healthy. If expansion continues, consider locking in long-term finance (e.g., term loans) to replace short-term borrowings, reducing refinancing risk.
- Plan for the Next Stage: As the company grows beyond the small company thresholds, proactively prepare for more comprehensive reporting requirements. This will build additional transparency and credibility with stakeholders.